[Pretreatment with cilostazol protects against the vascular endothelial damage after ischemia/reperfusion].
Iba
Toshiaki
T
toshiiba@med.juntendo.ac.jp
D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D000077407:Cilostazol; D004176:Dipyridamole / Q000494:pharmacology; D042783:Endothelial Cells / Q000187:drug effects* / Q000502:physiology; D019194:Ischemic Preconditioning; D051379:Mice; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D015427:Reperfusion Injury / Q000517:prevention & control*; D013777:Tetrazoles / Q000627:therapeutic use*
D010726:Phosphodiesterase Inhibitors; D013777:Tetrazoles; D004176:Dipyridamole; D000077407:Cilostazol; D001241:Aspirin